Tourmaline Historical Income Statement
| TRML Stock | 17.85 0.64 3.72% |
Historical analysis of Tourmaline Bio income statement accounts such as Total Other Income Expense Net of 17.3 M, Interest Expense of 18.4 K, Selling General Administrative of 23.9 M or Total Revenue of 0.0 can show how well Tourmaline Bio performed in making a profits. Evaluating Tourmaline Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tourmaline Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Tourmaline Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tourmaline Bio is a good buy for the upcoming year.
Tourmaline | Build AI portfolio with Tourmaline Stock |
About Tourmaline Income Statement Analysis
Tourmaline Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tourmaline Bio shareholders. The income statement also shows Tourmaline investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Tourmaline Bio Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tourmaline Bio. It is also known as Tourmaline Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Tourmaline Bio income statement and represents the costs associated with goods and services Tourmaline Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Tourmaline Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tourmaline Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.At this time, Tourmaline Bio's Other Operating Expenses is quite stable compared to the past year. Research Development is expected to rise to about 70.3 M this year, although the value of Gross Profit will most likely fall to (39.8 K).
| 2022 | 2023 | 2024 | 2025 (projected) | Total Operating Expenses | 19.7M | 45.4M | 89.7M | 94.2M | Cost Of Revenue | 6K | 33K | 29.7K | 28.2K |
Tourmaline Bio income statement Correlations
Click cells to compare fundamentals
Tourmaline Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tourmaline Bio income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 447K | 904.0 | 6K | 33K | (16.5M) | (15.7M) | |
| Gross Profit | (447K) | (623K) | (6K) | (33K) | (38.0K) | (39.8K) | |
| Other Operating Expenses | 22.7M | 904.0 | 19.7M | 45.4M | 52.2M | 54.8M | |
| Operating Income | (22.7M) | (904.0) | (19.7M) | (45.4M) | (89.7M) | (85.2M) | |
| Ebit | (22.7M) | (46.9M) | (19.7M) | (45.4M) | (73.2M) | (69.5M) | |
| Research Development | 15.3M | 212.0 | 17.5M | 32.4M | 67.0M | 70.3M | |
| Ebitda | (22.2M) | (46.9M) | (19.7M) | (45.4M) | (89.7M) | (85.2M) | |
| Cost Of Revenue | 447K | 623K | 6K | 33K | 29.7K | 28.2K | |
| Total Operating Expenses | 22.2M | 904.0 | 19.7M | 45.4M | 89.7M | 94.2M | |
| Income Before Tax | (22.7M) | (904.0) | (19.7M) | (42.1M) | (73.2M) | (69.5M) | |
| Net Income | (22.7M) | (904.0) | (19.7M) | (42.1M) | (73.2M) | (69.5M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.